94
Participants
Start Date
September 30, 2008
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
IPI-926
Oral daily dosing
Johns Hopkins Uninversity, Baltimore
University of Colorado Health Science Center, Aurora
TGen Clinical Research Service at Scottsdale Healthcare, Scottsdale
Stanford University, Redwood City
McGill University Jewish General Hospital, Montreal
Lead Sponsor
Infinity Pharmaceuticals, Inc.
INDUSTRY